Banks - Regional
Build Your Comparison
Side-by-side financial analysisStock Comparison
BHRB vs NKSH vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Diversified
BHRB vs NKSH vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Diversified |
| Market Cap | $1.01B | $231M | $896.00B |
| Revenue (TTM) | $487M | $85M | $280.33B |
| Net Income (TTM) | $117M | $16M | $57.05B |
| Gross Margin | 69.1% | 65.1% | 60.0% |
| Operating Margin | 29.7% | 22.5% | 25.9% |
| Forward P/E | 8.3x | 11.3x | 14.4x |
| Total Debt | $537M | $2M | $942.38B |
| Cash & Equiv. | $53M | $8M | $343.34B |
BHRB vs NKSH vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Burke & Herbert Fin… (BHRB) | 100 | 155.3 | +55.3% |
| National Bankshares… (NKSH) | 100 | 127.0 | +27.0% |
| JPMorgan Chase & Co. (JPM) | 100 | 341.0 | +241.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BHRB vs NKSH vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BHRB is the clearest fit if your priority is growth exposure and valuation efficiency.
- Rev growth 23.7%, EPS growth 231.2%
- PEG 0.45 vs JPM's 0.81
- NIM 3.7% vs JPM's 2.2%
NKSH has the current edge in this matchup, primarily because of its strength in income & stability and sleep-well-at-night.
- Dividend streak 0 yrs, beta 0.73, yield 4.2%
- Lower volatility, beta 0.73, Low D/E 1.1%, current ratio 1203.84x
- Beta 0.73, yield 4.2%, current ratio 1203.84x
JPM is the clearest fit if your priority is long-term compounding.
- 465.8% 10Y total return vs BHRB's 80.9%
- Efficiency ratio 0.3% vs NKSH's 0.4% (lower = leaner)
- Efficiency ratio 0.3% vs NKSH's 0.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 23.7% NII/revenue growth vs JPM's 3.3% | |
| Value | Lower P/E (8.3x vs 11.3x), PEG 0.45 vs 140.16 | |
| Quality / Margins | Efficiency ratio 0.3% vs NKSH's 0.4% (lower = leaner) | |
| Stability / Safety | Beta 0.73 vs JPM's 0.94, lower leverage | |
| Dividends | 4.2% yield, vs JPM's 1.9% | |
| Momentum (1Y) | +42.4% vs BHRB's +17.9% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs NKSH's 0.4% |
BHRB vs NKSH vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
BHRB vs NKSH vs JPM — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
BHRB leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 3289.7x NKSH's $85M. BHRB is the more profitable business, keeping 24.1% of every revenue dollar as net income compared to NKSH's 18.6%.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $487M | $85M | $280.3B |
| EBITDAEarnings before interest/tax | $162M | $20M | $81.4B |
| Net IncomeAfter-tax profit | $117M | $16M | $57.0B |
| Free Cash FlowCash after capex | $96M | $17M | $100.9B |
| Gross MarginGross profit ÷ Revenue | +69.1% | +65.1% | +60.0% |
| Operating MarginEBIT ÷ Revenue | +29.7% | +22.5% | +25.9% |
| Net MarginNet income ÷ Revenue | +24.1% | +18.6% | +20.4% |
| FCF MarginFCF ÷ Revenue | +19.7% | +20.5% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +53.8% | +91.7% | +16.0% |
Valuation Metrics
BHRB leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 8.7x trailing earnings, BHRB trades at a 46% valuation discount to JPM's 16.0x P/E. Adjusting for growth (PEG ratio), BHRB offers better value at 0.47x vs NKSH's 140.16x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $1.0B | $231M | $896.0B |
| Enterprise ValueMkt cap + debt − cash | $1.5B | $225M | $1.50T |
| Trailing P/EPrice ÷ TTM EPS | 8.66x | 14.59x | 16.00x |
| Forward P/EPrice ÷ next-FY EPS est. | 8.29x | 11.28x | 14.40x |
| PEG RatioP/E ÷ EPS growth rate | 0.47x | 140.16x | 0.90x |
| EV / EBITDAEnterprise value multiple | 10.29x | 11.74x | 18.36x |
| Price / SalesMarket cap ÷ Revenue | 2.05x | 2.71x | 3.20x |
| Price / BookPrice ÷ Book value/share | 1.18x | 1.25x | 2.47x |
| Price / FCFMarket cap ÷ FCF | 10.48x | 15.27x | 8.88x |
Profitability & Efficiency
NKSH leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $9 for NKSH. NKSH carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), NKSH scores 8/9 vs JPM's 5/9, reflecting strong financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | +14.6% | +9.0% | +15.9% |
| ROA (TTM)Return on assets | +1.5% | +0.9% | +1.3% |
| ROICReturn on invested capital | +8.4% | +8.4% | +4.5% |
| ROCEReturn on capital employed | +3.5% | +1.9% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 8 | 5 |
| Debt / EquityFinancial leverage | 0.63x | 0.01x | 2.60x |
| Net DebtTotal debt minus cash | $484M | -$6M | $599.0B |
| Cash & Equiv.Liquid assets | $53M | $8M | $343.3B |
| Total DebtShort + long-term debt | $537M | $2M | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | 0.97x | 0.64x | 0.74x |
Total Returns (Dividends Reinvested)
JPM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $12,431 for NKSH. Over the past 12 months, NKSH leads with a +42.4% total return vs BHRB's +17.9%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs BHRB's -3.0% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | +10.4% | +12.3% | -0.5% |
| 1-Year ReturnPast 12 months | +17.9% | +42.4% | +21.8% |
| 3-Year ReturnCumulative with dividends | -8.8% | +37.2% | +138.2% |
| 5-Year ReturnCumulative with dividends | +51.7% | +24.3% | +118.2% |
| 10-Year ReturnCumulative with dividends | +80.9% | +54.9% | +465.8% |
| CAGR (3Y)Annualised 3-year return | -3.0% | +11.1% | +33.6% |
Risk & Volatility
Evenly matched — NKSH and JPM each lead in 1 of 2 comparable metrics.
Risk & Volatility
NKSH is the less volatile stock with a 0.73 beta — it tends to amplify market swings less than JPM's 0.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 95.1% from its 52-week high vs NKSH's 90.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.81x | 0.73x | 0.94x |
| 52-Week HighHighest price in past year | $70.90 | $40.00 | $337.25 |
| 52-Week LowLowest price in past year | $55.40 | $24.74 | $262.71 |
| % of 52W HighCurrent price vs 52-week peak | +94.6% | +90.8% | +95.1% |
| RSI (14)Momentum oscillator 0–100 | 64.0 | 55.1 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 146K | 49K | 7.0M |
Analyst Outlook
Evenly matched — NKSH and JPM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BHRB as "Buy", NKSH as "Buy", JPM as "Buy". Consensus price targets imply 10.3% upside for BHRB (target: $74) vs 5.9% for JPM (target: $340). For income investors, NKSH offers the higher dividend yield at 4.16% vs JPM's 1.86%.
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $74.00 | — | $339.75 |
| # AnalystsCovering analysts | 3 | 4 | 61 |
| Dividend YieldAnnual dividend ÷ price | +3.4% | +4.2% | +1.9% |
| Dividend StreakConsecutive years of raises | 2 | 0 | 15 |
| Dividend / ShareAnnual DPS | $2.26 | $1.51 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +3.9% |
BHRB leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). NKSH leads in 1 (Profitability & Efficiency). 2 tied.
BHRB vs NKSH vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BHRB or NKSH or JPM a better buy right now?
For growth investors, Burke & Herbert Financial Services Corp.
(BHRB) is the stronger pick with 23. 7% revenue growth year-over-year, versus 3. 3% for JPMorgan Chase & Co. (JPM). Burke & Herbert Financial Services Corp. (BHRB) offers the better valuation at 8. 7x trailing P/E (8. 3x forward), making it the more compelling value choice. Analysts rate Burke & Herbert Financial Services Corp. (BHRB) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BHRB or NKSH or JPM?
On trailing P/E, Burke & Herbert Financial Services Corp.
(BHRB) is the cheapest at 8. 7x versus JPMorgan Chase & Co. at 16. 0x. On forward P/E, Burke & Herbert Financial Services Corp. is actually cheaper at 8. 3x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Burke & Herbert Financial Services Corp. wins at 0. 45x versus National Bankshares, Inc. 's 140. 16x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — BHRB or NKSH or JPM?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +118. 2%, compared to +24. 3% for National Bankshares, Inc. (NKSH). Over 10 years, the gap is even starker: JPM returned +465. 8% versus NKSH's +54. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BHRB or NKSH or JPM?
By beta (market sensitivity over 5 years), National Bankshares, Inc.
(NKSH) is the lower-risk stock at 0. 73β versus JPMorgan Chase & Co. 's 0. 94β — meaning JPM is approximately 30% more volatile than NKSH relative to the S&P 500. On balance sheet safety, National Bankshares, Inc. (NKSH) carries a lower debt/equity ratio of 1% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — BHRB or NKSH or JPM?
By revenue growth (latest reported year), Burke & Herbert Financial Services Corp.
(BHRB) is pulling ahead at 23. 7% versus 3. 3% for JPMorgan Chase & Co. (JPM). On earnings-per-share growth, the picture is similar: Burke & Herbert Financial Services Corp. grew EPS 231. 2% year-over-year, compared to 1. 5% for JPMorgan Chase & Co.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BHRB or NKSH or JPM?
Burke & Herbert Financial Services Corp.
(BHRB) is the more profitable company, earning 23. 9% net margin versus 18. 6% for National Bankshares, Inc. — meaning it keeps 23. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BHRB leads at 29. 5% versus 22. 5% for NKSH. At the gross margin level — before operating expenses — BHRB leads at 69. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BHRB or NKSH or JPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Burke & Herbert Financial Services Corp. (BHRB) is the more undervalued stock at a PEG of 0. 45x versus National Bankshares, Inc. 's 140. 16x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Burke & Herbert Financial Services Corp. (BHRB) trades at 8. 3x forward P/E versus 14. 4x for JPMorgan Chase & Co. — 6. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BHRB: 10. 3% to $74. 00.
08Which pays a better dividend — BHRB or NKSH or JPM?
All stocks in this comparison pay dividends.
National Bankshares, Inc. (NKSH) offers the highest yield at 4. 2%, versus 1. 9% for JPMorgan Chase & Co. (JPM).
09Is BHRB or NKSH or JPM better for a retirement portfolio?
For long-horizon retirement investors, JPMorgan Chase & Co.
(JPM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 94), 1. 9% yield, +465. 8% 10Y return). Both have compounded well over 10 years (JPM: +465. 8%, BHRB: +80. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BHRB and NKSH and JPM?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: BHRB is a small-cap high-growth stock; NKSH is a small-cap deep-value stock; JPM is a large-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.